In our study, we detected that TMZ monotherapy stimulates Th2 polarization of tumor-infiltrating CD11b+ GAMs (Fig. S7) in contrast to the anti-tumor activation profile of GAMs in the T+H combinatory therapy group. This evidence concerns the gene ITGAM and neoplasm.